Insider Trading History of Kkr Genetic Disorder Gp Llc


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Kkr Genetic Disorder Gp Llc since year 2005. The trader's CIK number is 1780428. At the time of the last reporting, Kkr Genetic Disorder Gp Llc was the 10% Owner of Bridgebio Pharma, Inc. . (stock ticker symbol BBIO). See this page for all insider trading activities at Bridgebio Pharma, Inc. .


Stock purchases, sales, and option exercises reported by insider Kkr Genetic Disorder Gp Llc since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2019-07-01 BBIO Bridgebio Pharma, Inc. Buy 2,647,100 17.00 45,000,700

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Kkr Genetic Disorder Gp Llc (10% Owner of Bridgebio Pharma, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.




Real-time Insider Trading

Insider Officer Cluster Trading

Top Officer Buys of the Week

Top Officer Buys of the Month